Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Illumina (ILMN) Optics for Genomics -- Ignore unavailable to you. Want to Upgrade?

To: mopgcw who wrote (57)	7/14/2003 12:49:20 AM
From: mopgcw	Read Replies (1) \| Respond to of 276

and another one sold: Johns Hopkins University Purchases Production-Scale SNP Genotyping BeadLab from Illumina Wednesday July 9, 5:11 pm ET Illumina's BeadArray(TM) Technology to Enable Large-Scale Genetic Research and Expanded Scope of SNP Genotyping Services at the University SAN DIEGO--(BUSINESS WIRE)--July 9, 2003-- Illumina, Inc. (Nasdaq: ILMN - News) announced today an agreement with Johns Hopkins University for the purchase of Illumina's BeadLab. The BeadLab, a production-scale SNP (single nucleotide polymorphism) genotyping laboratory, will constitute an integral component of the University's state-of-the-art resources devoted to understanding the functional implications of sequence variation in the human genome and other model organisms. ADVERTISEMENT The BeadLab genotyping laboratory will be installed in the University's Genetic Resources Core Facility (GRCF) and used by GRCF to perform whole-genome and fine-mapping studies against hundreds to thousands of samples. Such large-scale studies will help researchers understand the role of genetic variation in disease susceptibility and facilitate the identification of genes associated with complex diseases. In addition, the agreement grants GRCF the opportunity to offer fee-based genotyping services to researchers outside the University. The SNP genotyping facility will also be used by the Center for Inherited Disease Research (CIDR), which is supported through a federally funded contract to Johns Hopkins University. CIDR concentrates its efforts on the study and understanding of multifactorial hereditary diseases. The genotyping laboratory solution is built around Illumina's proprietary BeadArray technology and features high sample throughput from unprecedented multiplex levels. The multiplex levels combined with the BeadLab's integrated, automated laboratory solution generates low running cost per SNP scored. The complete offering is fully integrated to ensure optimal SNP genotyping performance. Included in the turnkey offering are the BeadArray Reader, GoldenGate(TM) assay reagents and protocols, LIMS and analytical software, fluid-handling robotics, and access to Sentrix(TM) Array Matrices, along with installation, start-up, training, and support services. When installed, the genotyping laboratory at GRCF will have the capacity to produce routinely six hundred thousand genotypes per day. The BeadLab agreement follows large studies previously completed by Illumina's Genotyping Services facility for Johns Hopkins. One of these studies was designed to identify genetic factors associated with cleft lip and palate, isolated craniosynostosis, and related conditions. "Johns Hopkins is a world leader in genetic research," stated Jay Flatley, Illumina President and CEO. "We're very pleased to expand our relationship with the University and help accelerate their pioneering efforts in this field. Illumina's genotyping system provides a high degree of accuracy and sample throughput along with low cost per genotype. This new capability will enable Johns Hopkins to perform significantly larger-scale studies while offering the opportunity to complete those studies in a very timely manner." In addition to conducting studies in molecular biology and genetics, GRCF sponsors various educational programs and hosts product seminars and a biennial symposium. Additional information about Johns Hopkins University's Genetic Research Core Facility can be found at grcf.jhmi.edu. More information regarding CIDR is available at cidr.jhmi.edu. Illumina (www.illumina.com) is developing next-generation tools that permit large-scale analysis of genetic variation and function. The Company's proprietary BeadArray(TM) technology provides the throughput, cost effectiveness and flexibility to enable researchers in the life sciences and pharmaceutical industries to perform the billions of tests necessary to extract medically valuable information from advances in genomics and proteomics. This information will help pave the way to personalized medicine.